Swedish University conducts a clinical trial of Electronic Patient Reported Outcome Measures (ePROMs) in Patients With Breast Disease
Photo by Olga Kononenko
Uppsala University is enrolling patients into the clinical trial investigating of Electronic Patient Reported Outcome Measures (ePROMs) in Patients With Breast Disease: An Open-label, Randomized Controlled Trial on Patient Reported Experience Measures (PREMs) and Effectivity (PREMs_PROMs).
In recent years, large interest in the conduct and focus of clinical trials has focused to patient related outcomes and value-based healthcare. Patient Reported Outcome MeasureS, (PROMs) has become one of the standard instruments used for measuring outcomes; multiple PROMS have been extensively validated and are used in many clinical studies, but also in clinical routine. Additionally, Patient Reported Experience MeasureS (PREMS) allow for real-time feedback on the integration of care and can subsequently drive changes in health provision systems. In the present trial, the mode of delivery of PROMS is examined in terms of effectivity and patient experience (PREMS) in the setting of breast disease.
The trial is designed to enroll male and female 18 years and older and is being conducted in the Uppsala University Hospital, Uppsala, Sweden.
The study start date is September 1, 2019.
The patients that can be enrolled into this study include:
- Patients seeking or being treated for perceived or verified, benign or malignant breast disease.
- Women undergoing screening mammography.
Among the exclusion criteria are:
- Linguistic barriers
- Deprivation of liberty
Uppsala University (Uppsala universitet) is a research university in Uppsala, Sweden. Founded in 1477, it is the oldest university in Sweden and all of the Nordic countries still in operation. It has ranked among the world's 100 best universities in several high-profile international rankings during recent years. The university uses "Gratiae veritas naturae" as its motto and embraces natural sciences.
This page provides a more detailed overview of this clinical trial: https://ichgcp.net/clinical-trials-registry/NCT04718324
